Intercure Ltd.
Hertzliya, Israel ยท Pharmaceuticals
Intercure Ltd. is a pharmaceuticals company based in Hertzliya, Israel. In a Form D filed with the SEC on August 19, 2026, it reported an offering of indefinite size with no sales completed at the time of filing. The first sale in the offering took place on June 15, 2026.
- Amount raised
- None reported yet
- Offering size
- Indefinite
- Investors so far
- 15
- First sale
- June 15, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Hertzliya, Israel
- Incorporated
- Israel
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | โ | Indefinite | 15 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Curadel Surgical Innovations, Inc. | Bonita Springs, FL | Health Care | $49.8M | $57.5M | |
| Axelyf, Inc. | Chestnut Hill, MA | Health Care | $2.6M | $2.7M | |
| iPill Inc. | Rowland Heights, CA | Health Care | $1.3M | $1.5M | |
| Dvant Pharma, Inc. | Superior Township, MI | Health Care | $1.2M | $3.1M | |
| FibroBiologics, Inc. | Houston, TX | Health Care | $1.2M | $1.2M | |
| Vimy Pharmaceuticals Inc. | Toronto, Ontario, Canada | Health Care | $1M | $1M |